FDA finalizes guidance on off-label communications
Regulatory NewsMary Ellen Schneider
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesGuidanceMedical DevicesOff-label promotionPharmaceuticalsUnited StatesUS Food and Drug Administration (FDA)